Labaton Sucharow LLP Files a Class Action Lawsuit on Behalf of Investors in Allscripts Healthcare Solutions, Inc. -- MDRX

Labaton Sucharow LLP Files a Class Action Lawsuit on Behalf of Investors in
Allscripts Healthcare Solutions, Inc. -- MDRX

NEW YORK, May 2, 2012 (GLOBE NEWSWIRE) -- Labaton Sucharow LLP filed a class
action lawsuit on May 2, 2012 in the U.S. District Court for the Northern
District of Illinois. The lawsuit was filed on behalf of purchasers of
Allscripts Healthcare Solutions, Inc. ("Allscripts" or the "Company") common
stock between November 9, 2010, and April 26, 2012, inclusive (the "Class

The action charges Allscripts and certain of its officers with violations of
Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule
10b-5 promulgated thereunder.The Complaint alleges that, throughout the Class
Period, the Company, which was formed from the merger of Allscripts-Misys
Healthcare Solutions, Inc. and Eclypsis Corporation ("Eclypsis") in August
2010 (the "Merger"), misrepresented its progress in integrating Allscripts'
and Eclypsis' disparate systems and the Company's ability to translate its
fragmented product lines into revenues.

Allscripts is a provider of healthcare-related information technology
services, including systems that manage electronic health records, financial
and administrative performance, revenue cycle, and care and discharge
operations.The Complaint alleges that Allscripts concealed that: (a) the
process of developing a unified product offering after the Merger had suffered
debilitating setbacks, including major undisclosed schisms among the most
senior levels of the Company, which ultimately resulted in the loss of key
personnel and harmful upheaval in Company leadership; (b) a material portion
of Allscripts' revenue and net income was predicated on the successful
integration of these systems, and substantial business relationships had been
destroyed by the Company's inability to make material progress in this area;
and (c) as a result of the foregoing, Allscripts lacked a reasonable basis for
its claims of progress in post-Merger integration, sound operations,
profitable results, and continued growth.

The truth about Allscripts' condition was revealed on April 26, 2012,
following the close of the markets, when the Company announced its operating
results for the first quarter of 2012.Allscripts shocked the market by
reporting earnings sharply below guidance and expectations, as well as:
(a)the termination of the Chairman of its Board of Directors; (b) the
resignation of three Company directors; and (c) the resignation the Company's
Chief Financial Officer.In reaction to these revelations, Allscripts' stock
price fell $5.72 per share, or 35.7 percent, to close at $10.30 per share on
April 27, 2012, on extraordinary trading volume.

If you are a member of this Class you can view a copy of the complaint and
join this class action online at

If you purchased Allscripts common stock during the Class Period, you may be
able to seek appointment as Lead Plaintiff.Lead Plaintiff motion papers must
be filed with the U.S. District Court for the Northern District of Illinois no
later than July 2, 2012.A lead plaintiff is a court-appointed representative
for absent Class members.You do not need to seek appointment as lead
plaintiff to share in any Class recovery in this action.If you are a Class
member and there is a recovery for the Class, you can share in that recovery
as an absent Class member.You may retain counsel of your choice to represent
you in this action.

If you would like to consider serving as lead plaintiff or have any questions
about the lawsuit, you may contact one of our representatives, Rachel A. Avan,
Esq. of Labaton Sucharow LLP, at (888)753-2796 or (212) 907-0709, or via
email at

Labaton Sucharow LLP, with offices inNew York,New York and Wilmington,
Delaware, is one of the country's premier law firms representing institutional
investors in class action and complex securities litigation, as well as
consumers and businesses in class actions seeking to recover damages for
anticompetitive practices.The Firm has been a champion of investor and
consumer rights for nearly 50 years, seekingrecovery of current losses and
necessarygovernance reformsto protect investors and consumers. Labaton
Sucharowhas been recognized for its excellence by the courts and its
peers.More information about Labaton Sucharow is available at

Labaton Sucharow LLP
(888) 753-2796 or (212) 907-0709
Press spacebar to pause and continue. Press esc to stop.